Centre for Health Behaviours Research, School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Health Soc Care Community. 2012 Mar;20(2):137-44. doi: 10.1111/j.1365-2524.2011.01023.x. Epub 2011 Aug 16.
This article aims to demonstrate the perceptions of patients with chronic renal disease in Hong Kong towards the new vaccine for influenza A (H1N1), as well as the main disincentives. Little is known about the views of chronically ill patients on the H1N1 vaccine and even less about the underlying factors that motivate its low acceptance by this group. To explore these issues, this study adopted a qualitative approach by conducting in-depth, semi-structured interviews with 40 chronic renal disease patients in Hong Kong from December 2009 to March 2010. The participants were selected by purposive sampling from a patient with renal disease self-help alliance, which has over 4000 members with chronic renal diseases coming from nine public hospitals. Data were analysed using thematic content analysis. Although vaccination was portrayed as one of the most effective methods to prevent influenza A (H1N1), chronically ill participants in this study showed reluctance towards it. Six disincentives for them to receive H1N1 vaccines were identified: perceptions of H1N1 vaccine as unsafe, cultural perception of vaccines as harmful, the belief that seasonal influenza vaccines provided immunity against influenza A (H1N1), inaccessibility for receiving the H1N1 vaccine, worries in contracting infectious diseases from vaccination locations and the financial cost. As chronically ill patients are one of the high-risk groups who can suffer from severe complications from influenza, understanding the underlying social, cultural and perceptual factors that prevent their immunisation is crucial to the design of a public health policy responsive to their needs.
本文旨在展示香港慢性肾病患者对甲型 H1N1 新流感疫苗的看法,以及主要的阻碍因素。对于慢性疾病患者对 H1N1 疫苗的看法,人们知之甚少,而对于导致该群体对其接受度低的潜在因素则知之更少。为了探讨这些问题,本研究采用定性方法,于 2009 年 12 月至 2010 年 3 月期间,对香港的 40 名慢性肾病患者进行了深入的半结构式访谈。参与者是通过有目的的抽样从肾病患者自助联盟中选出的,该联盟拥有超过 4000 名来自九家公立医院的慢性肾病患者。采用主题内容分析法对数据进行分析。尽管接种疫苗被认为是预防甲型 H1N1 流感的最有效方法之一,但本研究中的慢性疾病患者对此表示不情愿。他们对接受 H1N1 疫苗有六个阻碍因素:对 H1N1 疫苗的安全性的看法、对疫苗的文化看法认为其有害、认为季节性流感疫苗能提供针对甲型 H1N1 流感的免疫力、难以获得 H1N1 疫苗、担心在接种疫苗的地方感染传染病,以及经济成本。由于慢性疾病患者是可能因流感而患上严重并发症的高风险群体之一,了解阻止他们免疫接种的潜在社会、文化和认知因素对于制定响应他们需求的公共卫生政策至关重要。